<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Asthma in Children - Part 3: Exacerbation Management</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="asthma-pharmacological-management.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 75%;"></div>
                        </div>
                       <span class="progress-text">Part 3 of 4</span>
                    </div>
                    <a href="status-astmaticus.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Asthma in Children, Part 3: Exacerbation Management</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: exacerbation-management -->
                <section id="exacerbation-management" class="content-section" aria-labelledby="section-heading-42">
                    <h2 id="section-heading-42" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Management of Exacerbation</span>
                    </h2>
                    <div class="content-card">
                        <p>Clinical findings (ABC), supplemented by objective tests, should be used to assess the severity of an acute asthma exacerbation.</p>
                        <p>Clinical evaluation should be repeated frequently during the management of an acute asthma exacerbation to assess response to therapy.</p>
                    </div>
                </section>
                <!-- END: exacerbation-management -->
                
                <!-- START: assessment-of-severity -->
                <section id="assessment-of-severity" class="content-section" aria-labelledby="section-heading-43">
                    <h2 id="section-heading-43" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Assessment of Severity</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>History</strong></p>
                        <ul>
                            <li>time of onset of exacerbation</li>
                            <li>current medications and allergies</li>
                            <li>recent use of beta 2-agonists</li>
                            <li>Risk factors for severe, uncontrolled disease</li>
                        </ul>
                        <p><strong>Exam</strong></p>
                        <ul>
                            <li>vital signs</li>
                            <li>pulse oximetry</li>
                            <li>level of consciousness, anxiety, and agitation</li>
                            <li>breathlessness, wheezing, air entry, accessory muscle use, and retractions</li>
                        </ul>
                    </div>
                </section>
                <!-- END: assessment-of-severity -->

                <!-- START: pulmonary-index -->
                <section id="pulmonary-index" class="content-section" aria-labelledby="section-heading-44">
                    <h2 id="section-heading-44" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Pulmonary Index</span>
                    </h2>
                    <div class="content-card">
                        <p>An asthma score based on five clinical variables: RR, degree of wheezing, I/E ratio, accessory muscle use, and oxygen saturation. A score of 7-11 indicates moderate severity and a score of $\geq 12$ indicates a severe attack. It can be used to assess initial severity and to judge response to treatment.</p>
                        <h3 class="subsection-heading">PULMONARY INDEX SCORE</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Score</th>
                                        <th>RR</th>
                                        <th>Wheeze</th>
                                        <th>Insp/Exp Ratio</th>
                                        <th>Accessory Muscle</th>
                                        <th>SPO2</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>0</td>
                                        <td><30</td>
                                        <td>None</td>
                                        <td>2:1</td>
                                        <td>None</td>
                                        <td>99-100</td>
                                    </tr>
                                    <tr>
                                        <td>1</td>
                                        <td>31-45</td>
                                        <td>End Expiration</td>
                                        <td>1:1</td>
                                        <td>+</td>
                                        <td>96-98</td>
                                    </tr>
                                    <tr>
                                        <td>2</td>
                                        <td>46-60</td>
                                        <td>Entire Expiration</td>
                                        <td>1:2</td>
                                        <td>++</td>
                                        <td>93-95</td>
                                    </tr>
                                    <tr>
                                        <td>3</td>
                                        <td>>60</td>
                                        <td>Insp & Expiration</td>
                                        <td>1:3</td>
                                        <td>+++</td>
                                        <td><93</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><small>For ages 6-20 yrs: score 0; 21-35, score 1; 36-50, score 2; >50, score 3 (for RR)<br>If no wheezing due to minimal air entry, score 3<br>- <7 : mild attack<br>- 7-11 : moderately severe attack<br>- $\geq 12$ : severe attack</small></p>
                    </div>
                </section>
                <!-- END: pulmonary-index -->

                <!-- START: severity-classification -->
                <section id="severity-classification" class="content-section" aria-labelledby="section-heading-45">
                    <h2 id="section-heading-45" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Severity Classification</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th rowspan="2">Criteria</th>
                                        <th colspan="3">Severity</th>
                                    </tr>
                                    <tr>
                                        <th>Mild</th>
                                        <th>Moderate</th>
                                        <th>Severe</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Pulsus paradoxus</td>
                                        <td><10 mmHg</td>
                                        <td>10-20 mmHg</td>
                                        <td>>20-40 mmHg</td>
                                    </tr>
                                    <tr>
                                        <td>Wheeze</td>
                                        <td>Expiratory</td>
                                        <td>Expiratory and inspiratory</td>
                                        <td>Soft breath sounds</td>
                                    </tr>
                                    <tr>
                                        <td>RR/min</td>
                                        <td><40</td>
                                        <td>>40</td>
                                        <td>>40</td>
                                    </tr>
                                    <tr>
                                        <td rowspan="4">Additional signs</td>
                                        <td>Speaks normally</td>
                                        <td>Difficulty feeding</td>
                                        <td>Unable to speak</td>
                                    </tr>
                                    <tr>
                                        <td>Maybe alert</td>
                                        <td>Intercostal retraction</td>
                                        <td>Confused</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td></td>
                                        <td>Possible cyanosis</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td></td>
                                        <td>Use of accessory muscles</td>
                                    </tr>
                                    <tr>
                                        <td>Arterial O2 Sat.</td>
                                        <td>>95%</td>
                                        <td>91-95%</td>
                                        <td><91%</td>
                                    </tr>
                                    <tr>
                                        <td>PEF rate (% predicted)</td>
                                        <td>70-90</td>
                                        <td>50-70</td>
                                        <td><50</td>
                                    </tr>
                                    <tr>
                                        <td>PaCO$_{2}$ (mmHg)</td>
                                        <td><35</td>
                                        <td><40</td>
                                        <td>>40</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: severity-classification -->

                <!-- START: simplified-severity-classification -->
                <section id="simplified-severity-classification" class="content-section" aria-labelledby="section-heading-46">
                    <h2 id="section-heading-46" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Simplified Classification of Severity of Acute Asthma in Children 5 Yrs or Below</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Symptoms</th>
                                        <th>Mild exacerbation</th>
                                        <th>Severe Exacerbation <sup>a</sup></th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Altered consciousness</td>
                                        <td>No</td>
                                        <td>Agitated, confused or drowsy</td>
                                    </tr>
                                    <tr>
                                        <td>Oximetry on presentation (SaO2) <sup>b</sup></td>
                                        <td>$\geq 94\%$</td>
                                        <td><90%</td>
                                    </tr>
                                    <tr>
                                        <td>Talks in <sup>c</sup></td>
                                        <td>Sentences</td>
                                        <td>Words</td>
                                    </tr>
                                    <tr>
                                        <td>Pulse rate <sup>d</sup></td>
                                        <td><100 bpm</td>
                                        <td>>200bpm (0-3yr)<br>>180bpm (4-5yr)</td>
                                    </tr>
                                    <tr>
                                        <td>Central cyanosis</td>
                                        <td>Absent</td>
                                        <td>Likely to be present</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><small>a. any of these signs indicate a severe exacerbation<br>b. oximetry performed before treatment with oxygen or bronchodilator<br>c. the normal developmental ability of the child taken into account<br>d. bpm = beats per minute</small></p>
                    </div>
                </section>
                <!-- END: simplified-severity-classification -->

                <!-- START: acute-exacerbation-goals -->
                <section id="acute-exacerbation-goals" class="content-section" aria-labelledby="section-heading-47">
                    <h2 id="section-heading-47" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Acute Asthma Exacerbations</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>Goals</strong></p>
                        <ul>
                            <li>Rapid reversal of airflow obstruction</li>
                            <li>Correction of hypoxemia (O2) and/or severe hypercapnia</li>
                            <li>Reduction of likelihood of recurrence by intensifying baseline therapy.</li>
                        </ul>
                        <h3 class="subsection-heading">Supportive Therapy</h3>
                        <p>Supplemental oxygen, fluids as necessary, and frequent monitoring of response to therapy.</p>
                    </div>
                </section>
                <!-- END: acute-exacerbation-goals -->

                <!-- START: other-considerations -->
                <section id="other-considerations" class="content-section" aria-labelledby="section-heading-48">
                    <h2 id="section-heading-48" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Other Considerations in Acute Management</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Hydration</h3>
                        <p>Oral fluids are preferred for most cases during early phase management, and for older children and adolescents.</p>
                        <p>IV fluids may be beneficial in:</p>
                        <ul>
                            <li>Severe illness and inability to take adequate fluid orally</li>
                            <li>Assess hydration status and administer judiciously (80-100% of normal requirement)</li>
                        </ul>
                        
                        <h3 class="subsection-heading">Not Recommended</h3>
                        <ul>
                            <li><strong>Chest physiotherapy / incentive spirometry:</strong> Can trigger/worsen broncho-constriction.</li>
                            <li><strong>Mucolytics and Cough syrups:</strong> Can worsen the bronchial obstruction.</li>
                            <li><strong>Sedatives (strictly avoid)</strong></li>
                            <li><strong>Hydration with large volumes of fluids for older children</strong> (may be necessary for young children)</li>
                            <li><strong>Antibiotics</strong> (unless signs of infection)</li>
                            <li><strong>Epinephrine/adrenaline</strong> (except for anaphylaxis and angioedema)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: other-considerations -->

                <!-- START: golden-hour -->
                <section id="golden-hour" class="content-section" aria-labelledby="section-heading-49">
                    <h2 id="section-heading-49" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Golden Hour: Medical Management</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Medication</th>
                                        <th>Mild</th>
                                        <th>Moderate</th>
                                        <th>Severe</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>SABA</td>
                                        <td>MDI 2-4 puffs every 20 min x 1 hour</td>
                                        <td>MDI 2-4 puffs every 20 min<br>Nebulise 2.5 - 5.0 mg every 20 min</td>
                                        <td>-MDI 4-8 puffs every 20 min (face mask all ages)<br>-Nebulise 2.5 mg (child) - 5.0 mg (adolescent) every 20 min</td>
                                    </tr>
                                    <tr>
                                        <td>Oxygen (maintain SaO2 > 94%)</td>
                                        <td>Not required</td>
                                        <td>By face mask (5l/min)</td>
                                        <td>By face mask</td>
                                    </tr>
                                    <tr>
                                        <td>Anticholinergic<br>Ipratropium bromide</td>
                                        <td>Not required</td>
                                        <td>-Nebulised 125-250 mcg child, 500 mcg adolescent or<br>-MDI 2-4 puffs every 20 min</td>
                                        <td>-Nebulised 125-250mcg child, 500 mcg adolescent or<br>-MDI 4 puffs (child) - 8 puffs (adolescent) every 20 min</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: golden-hour -->

                <!-- START: after-golden-hour -->
                <section id="after-golden-hour" class="content-section" aria-labelledby="section-heading-50">
                    <h2 id="section-heading-50" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">After Golden Hour: Poor Response - Admit to Hospital</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Medication</th>
                                        <th>Dose</th>
                                        <th>Indication</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>SABA</td>
                                        <td>MDI 6-10 puffs every 2 hours OR Nebulise 0.15 mg/kg every 2 hr</td>
                                        <td>All</td>
                                    </tr>
                                    <tr>
                                        <td>Ipratropium</td>
                                        <td>MDI 2 puffs every 12 hours OR Nebulise 125-250 mcg (child) 500 mcg (adolescent) every 12 hour</td>
                                        <td>All</td>
                                    </tr>
                                    <tr>
                                        <td>Corticosteroids (oral, 4 hr onset of action)</td>
                                        <td>-Prednisolone 1 - 2 mg/kg for 5 days<br>-Methylprednisolone 1mg/kg every 12 hr x 24 hr, then once daily to 5th day<br>-IV hydrocortisone 50-400 mg/day</td>
                                        <td>All</td>
                                    </tr>
                                    <tr>
                                        <td>Oxygen</td>
                                        <td>By mask 5L/min, aim to maintain SaO2 >94%</td>
                                        <td>Child SaO2 < 94%<br>Adolescent SaO2 < 90%</td>
                                    </tr>
                                    <tr>
                                        <td>MgSO4</td>
                                        <td>25-75mg/kg IV slow bolus</td>
                                        <td>Persistent Severe Attack</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: after-golden-hour -->

                <!-- START: acute-pharmacotherapy -->
                <section id="acute-pharmacotherapy" class="content-section" aria-labelledby="section-heading-51">
                    <h2 id="section-heading-51" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Pharmacotherapy for Acute Exacerbations</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Inhaled SABAs (Albuterol)</h3>
                        <p>Administration by intermittent nebulization, continuous nebulization, or MDI with spacer (MDI-S). Small volume nebulizers (SVNs) or MDI-S are equally effective for children of all ages and a wide range of illness severity. Meta-analyses indicate that the administration of beta 2-agonists via MDI-S (4 to 12 puffs) is at least as effective, and possibly superior, to delivery of medication by SVN in reversing bronchospasm in infants and children.</p>
                        
                        <h4 class="subsubsection-heading">Continuous Delivery</h4>
                        <p>This has similar outcomes and side effect profiles to intermittent therapy. It is indicated for children who require frequent treatments for an extended period.</p>
                        
                        <h4 class="subsubsection-heading">Dosing and Administration</h4>
                        <ol>
                            <li>Intermittent albuterol nebulization: 0.15 mg/kg (2.5-5 mg)</li>
                            <li>Administer every 20-30 mins for three doses.</li>
                            <li>Beyond this, frequency may be limited by side effects.</li>
                            <li>If no improvement after 3 doses and the patient is not experiencing adverse effects, they may be treated every 30-45 minutes or switched to continuous therapy.</li>
                        </ol>
                        <p>Albuterol MDI-S: 1/4 - 1/3 puff/kg (22.5 to 30 microgram/kg) with a max of 10 puffs (900 microgram). The dose can be repeated every 20-30 min for three doses, then every 1 to 4 hours as needed.</p>
                        
                        <h3 class="subsection-heading">Glucocorticoids</h3>
                        <p>Reduces the airway edema and secretions associated with acute asthma exacerbations. Systemic glucocorticoids are indicated. Exceptions include patients who respond promptly to a single albuterol treatment or have mild exacerbations. Effects of systemic glucocorticoids may be noted within 2-3 hours of administration.</p>
                        
                        <h4 class="subsubsection-heading">Dose</h4>
                        <p>Depends on the agent and route:</p>
                        <ol>
                            <li><strong>Oral prednisone:</strong> initial dose is 2 mg/kg (maximum 60 mg), then 1 mg/kg twice daily for three to ten days.</li>
                            <li><strong>Dexamethasone:</strong> has a longer half-life than prednisone (36-72 hrs vs 18-36 hrs). Dose is 0.6 mg/kg (maximum dose 16 mg).</li>
                            <li><strong>Methylprednisolone:</strong> i.v. dose for acute asthma exacerbations is 1 to 2 mg/kg (maximum 60 mg).</li>
                        </ol>

                        <h3 class="subsection-heading">Inhaled Glucocorticoids</h3>
                        <p>Ongoing clinical research has shown mixed results so far for use in acute exacerbations.</p>

                        <h3 class="subsection-heading">Ipratropium Bromide</h3>
                        <p>Indicated in moderate to severe asthma exacerbations, combined with inhaled beta 2-agonists. Administered via SVN or MDI-S.</p>
                        <ul>
                            <li><strong>Dose:</strong> 250 mcg/dose (<20 kg); 500 mcg/dose (>20 kg). Administered with each of the first three albuterol treatments or the second and third treatments.</li>
                            <li><strong>Via MDI-S:</strong> 4-8 puffs (each puff is 18 microgram).</li>
                        </ul>

                        <h3 class="subsection-heading">Magnesium Sulfate</h3>
                        <p>I.V. magnesium sulfate benefits children with severe asthma. It is inexpensive with minimal adverse effects at the indicated doses. It is indicated in severe asthma exacerbation and moderate exacerbations with clinical deterioration despite treatment with beta 2-agonists, ipratropium, and systemic glucocorticoids. The dose is 75 mg/kg (maximum 2.5 g) IV administered over 20 minutes.</p>

                        <h3 class="subsection-heading">Parenteral Beta 2-Agonists</h3>
                        <p>Epinephrine and terbutaline (s.c. or i.v.). Subcutaneous beta 2-agonists may be superior to inhaled beta 2-agonists for severe exacerbations with poor inspiratory flow, or for anxious children who are uncooperative or have a suboptimal response to initial aerosolized therapy. Terbutaline produces fewer adverse effects than epinephrine.</p>
                        <ul>
                            <li><strong>S.c. terbutaline:</strong> 0.01 mg/kg per dose (1 mg/mL solution) with a max dose of 0.4 mg (0.4 mL). May be repeated every 20 min for three doses.</li>
                            <li><strong>S.c. epinephrine:</strong> 0.01 mL/kg of 1:1000 solution (1 mg/mL), with a max dose of 0.4 mL (0.4 mg). May be repeated every 20 min for 3 doses, then every 2-6 hrs as needed. Dosing interval may be decreased for children who continue with severe respiratory distress.</li>
                        </ul>
                        
                        <h3 class="subsection-heading">Nonstandard Therapies</h3>
                        <p>There is little data to support the routine use of heliox, ketamine, or leukotriene receptor antagonists in the treatment of children with acute asthma.</p>
                        <ol>
                            <li><strong>Heliox:</strong> A mixture of helium and oxygen may enhance beta 2-agonist delivery because the lower gas density results in decreased flow resistance.</li>
                            <li><strong>Ketamine:</strong> Has bronchodilating properties. It is the drug of choice for sedation and analgesia before intubating a child with asthma. Data is limited.</li>
                            <li><strong>Leukotriene receptor antagonists:</strong> Studies are largely confined to adults.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: acute-pharmacotherapy -->

                <!-- START: exacerbation-treatment-by-severity -->
                <section id="exacerbation-treatment-by-severity" class="content-section" aria-labelledby="section-heading-52">
                    <h2 id="section-heading-52" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Exacerbation Treatment by Severity</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Mild Exacerbation</h3>
                        <p>Salbutamol inhalation therapy administered via small volume nebulizer at 0.15 mg/kg (max 5 mg) or MDI at a dose of one-quarter to one-third puff/kg (maximum 10 puffs). If repeated doses are needed, they should be given every 20-30 mins for 3 doses. Consider administration of systemic glucocorticoids to those who fail to improve after one inhalation therapy.</p>
                        <h3 class="subsection-heading">Moderate Exacerbation</h3>
                        <p>Provide supplemental oxygen if oxygen saturation $\leq 92\%$ in room air. Administer Salbutamol nebulization combined with ipratropium (250 $\mu$g/dose if <20 kg; 500 $\mu$g/dose if >20 kg) every 20-30 mins for 3 doses or continuously. Patients who have received 3 doses of intermittent therapy and require additional Salbutamol may be treated intermittently every 30-45 mins or switched to continuous therapy.</p>
                    </div>
                </section>
                <!-- END: exacerbation-treatment-by-severity -->
                
                <!-- START: outpatient-management -->
                <section id="outpatient-management" class="content-section" aria-labelledby="section-heading-53">
                    <h2 id="section-heading-53" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Outpatient Assessment and Management of Acute Asthma</span>
                    </h2>
                    <div class="content-card">
                         <figure>
                            <img src="../assets/images/2025_06_14_202924806913c28d4c29g-121-1.jpg" alt="Flowchart for outpatient management of acute asthma, starting with initial assessment, classifying severity, and providing initial treatment with SABA. It then outlines disposition based on response: good response leads to discharge, incomplete response leads to continued treatment and observation, and poor response leads to hospital admission." class="content-image">
                         </figure>
                    </div>
                </section>
                <!-- END: outpatient-management -->
                
                <!-- START: hospital-admission -->
                <section id="hospital-admission" class="content-section" aria-labelledby="section-heading-54">
                    <h2 id="section-heading-54" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Hospital Admission</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Criteria for admission:</h3>
                        <ul>
                            <li>Children who require beta 2-agonist therapy more often than every 2-3 hrs</li>
                            <li>Have not improved after administration of systemic glucocorticoids</li>
                            <li>Who require supplemental oxygen</li>
                        </ul>
                        <p><strong>Other factors:</strong></p>
                        <ol>
                            <li>A history of rapid progression of severity in past exacerbations</li>
                            <li>Poor adherence with an outpatient medication regimen</li>
                            <li>Inadequate access to medical care</li>
                            <li>Poor social support system at home</li>
                        </ol>
                        <p>Inpatient treatment is typically a continuation of therapies and monitoring that have been started in the outpatient setting.</p>
                    </div>
                </section>
                <!-- END: hospital-admission -->

                <!-- START: icu-admission -->
                <section id="icu-admission" class="content-section" aria-labelledby="section-heading-55">
                    <h2 id="section-heading-55" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">ICU Admission</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Risk Factors for ICU Admission</h3>
                        <ul>
                            <li>History of ICU admissions, mechanical ventilation, or rapidly progressive and sudden respiratory deterioration</li>
                            <li>Seizures or syncope during an asthma exacerbation</li>
                            <li>Exacerbations precipitated by food</li>
                            <li>Use of more than two beta-agonist metered dose inhaler (MDI) canisters per month</li>
                            <li>Insufficient controller therapy or poor adherence to controller therapy</li>
                            <li>Denial of or failure to perceive the severity of illness</li>
                            <li>Associated depression or other psychiatric disorder</li>
                        </ul>
                        <h3 class="subsection-heading">Principles of ICU Management</h3>
                        <p>Children who fail to improve with initial treatment in the emergency department should be admitted to the ICU.</p>
                        <p>Management entails the use of corticosteroids, aggressive bronchodilator therapy, and close monitoring.</p>
                        <p>Mechanical ventilation is reserved for patients with continued progression toward respiratory failure despite maximal medical therapy.</p>
                        <p>The decision to intubate a patient should not be delayed until respiratory failure is imminent.</p>
                        <p>For patients progressing toward respiratory muscle fatigue, NPPV (Non-invasive Positive Pressure Ventilation) may avoid the need for intubation by easing the work of breathing while awaiting the maximal therapeutic effects of pharmacotherapy.</p>
                    </div>
                </section>
                <!-- END: icu-admission -->
                
                <!-- START: inpatient-management-severe -->
                <section id="inpatient-management-severe" class="content-section" aria-labelledby="section-heading-56">
                    <h2 id="section-heading-56" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Inpatient Assessment and Management of Acute Severe Asthma</span>
                    </h2>
                    <div class="content-card">
                         <figure>
                            <img src="../assets/images/2025_06_14_202924806913c28d4c29g-128-1.jpg" alt="Flowchart for inpatient management of severe asthma. It begins with admission and initial therapies like continuous SABA, IV corticosteroids, and oxygen. It outlines criteria for ICU transfer and details ICU therapies including IV bronchodilators and potential mechanical ventilation." class="content-image">
                         </figure>
                    </div>
                </section>
                <!-- END: inpatient-management-severe -->
                
                <!-- START: inpatient-pharmacotherapy -->
                <section id="inpatient-pharmacotherapy" class="content-section" aria-labelledby="section-heading-57">
                    <h2 id="section-heading-57" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Inpatient Pharmacotherapy</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>IV Corticosteroids:</strong> Methylprednisolone (2 to 4 mg/kg per day, with a maximum dose of 60 mg/day)</p>
                        <p><strong>Aggressive bronchodilator therapy consists of:</strong> Hourly or continuously delivered Salbutamol via nebulizer:</p>
                        <ul>
                            <li>For hourly administration, Salbutamol (0.15 mg/kg every hour, minimum 2.5 mg; maximum 5 mg), or</li>
                            <li>For continuous administration, Salbutamol:
                                <ul>
                                    <li>10 mg/hour for children who weigh 5 to 10 kg;</li>
                                    <li>15 mg/hour for children who weigh 10 to 20 kg; and</li>
                                    <li>20 mg/hour for children who weigh >20 kg.</li>
                                </ul>
                            </li>
                        </ul>
                        <p><strong>Ipratropium bromide:</strong> 250 microgram per dose for children who weigh <20 kg or are younger than 6 years of age; 500 microgram per dose for children who weigh >20 kg or are older than 6 years of age. The optimal duration of therapy with ipratropium bromide has not been established. However, a duration of 24 hours following admission is suggested.</p>
                        <p><strong>Magnesium sulphate:</strong> (25 to 75 mg/kg IV; maximum 2 grams) is administered upon arrival to the ICU if it has not been administered earlier.</p>
                        <p>For patients who fail to respond to aggressive inhaled bronchodilator therapy, the administration of intravenous bronchodilators may be considered:</p>
                        <ul>
                            <li>Terbutaline (10 microgram/kg IV loading dose administered over 10 minutes, followed by an infusion of 0.1 to 10 microgram/kg per minute), and/or</li>
                            <li>Aminophylline (6 mg/kg IV loading dose, followed by infusion of 0.6 to 1.5 mg/kg per hour).</li>
                        </ul>
                        <p>Terbutaline is usually started at 0.1 microgram/kg per minute and increased in 0.1 to 1 microgram/kg per minute increments every 30 minutes, often to a maximum dose of 10 microgram/kg per minute, until aeration and work of breathing improve.</p>
                    </div>
                </section>
                <!-- END: inpatient-pharmacotherapy -->

                <!-- START: other-measures-icu -->
                <section id="other-measures-icu" class="content-section" aria-labelledby="section-heading-58">
                    <h2 id="section-heading-58" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Other Measures</span>
                    </h2>
                    <div class="content-card">
                        <p>NPPV involves the delivery of positive airway pressure, either as continuous pressure (CPAP) or as mechanically assisted breaths (BiPAP), without placement of an artificial airway.</p>
                    </div>
                </section>
                <!-- END: other-measures-icu -->

                <!-- START: intubation -->
                <section id="intubation" class="content-section" aria-labelledby="section-heading-59">
                    <h2 id="section-heading-59" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Endotracheal Intubation</span>
                    </h2>
                    <div class="content-card">
                        <p>Indications for intubation in patients with acute severe asthma include:</p>
                        <ul>
                            <li>Hypoxemia despite provision of high concentrations of oxygen or NPPV (non-invasive positive pressure ventilation)</li>
                            <li>Severe and unremitting work of breathing (e.g., inability to speak)</li>
                            <li>Altered mental status</li>
                            <li>Respiratory or cardiac arrest</li>
                        </ul>
                        <h3 class="subsection-heading">Goals of Intubation</h3>
                        <ul>
                            <li>To take over the work of breathing from the exhausted patient and allow respiratory muscle rest.</li>
                            <li>To ensure adequate oxygenation.</li>
                            <li>To ensure sufficient (not necessarily "normal") gas exchange until airway obstruction can be reversed.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: intubation -->

                <!-- START: discharge -->
                <section id="discharge" class="content-section" aria-labelledby="section-heading-60">
                    <h2 id="section-heading-60" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Discharge Planning</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Discharge Criteria</h3>
                        <ul>
                            <li>Asthma symptoms & signs are considered mild</li>
                            <li>No requirement for supplemental oxygen</li>
                            <li>Receiving a treatment regimen that can be reasonably duplicated at home</li>
                        </ul>
                        <p>If patients have been receiving nebulized medications, they may be changed to MDI-spacer upon discharge.</p>
                        <ul>
                            <li>FEV1 >70 % of expected (if available)</li>
                        </ul>
                        <p>Access to medications & appropriate follow-up have to be confirmed.</p>
                        <p>Asthma education is complete.</p>
                        
                        <h3 class="subsection-heading">Discharge Medications</h3>
                        <p>The patient's preadmission medication regimen, asthma severity classification & asthma control should be reviewed and controller medications adjusted as indicated. Discharge medications should include a SABA, either via nebulizer or MDI with a spacer & oral glucocorticoids. SABA should be continued every 4-6 hours until the patient is seen in follow-up within 3-5 days. Oral glucocorticoids are usually continued for a total of 5 days.</p>
                    </div>
                </section>
                <!-- END: discharge -->
                
                <!-- START: delivery-devices -->
                <section id="delivery-devices" class="content-section" aria-labelledby="section-heading-61">
                    <h2 id="section-heading-61" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Delivery Devices</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_14_202924806913c28d4c29g-140-1.jpg" alt="A collage of various asthma medication delivery devices, including a metered-dose inhaler (MDI), an MDI with a spacer, a dry powder inhaler (DPI), and a nebulizer." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: delivery-devices -->

                <!-- START: differentials -->
                <section id="differentials" class="content-section" aria-labelledby="section-heading-62">
                    <h2 id="section-heading-62" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Differentials</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Acute</h3>
                        <ul>
                            <li>Bronchiolitis</li>
                            <li>Bronchitis</li>
                            <li>Laryngotracheobronchitis</li>
                            <li>Bacterial tracheitis</li>
                            <li>Foreign body aspiration</li>
                            <li>Esophageal foreign body</li>
                        </ul>
                        <h3 class="subsection-heading">Chronic or Recurrent</h3>
                        <ul>
                            <li><strong>Structural abnormalities:</strong> Tracheo-bronchomalacia, Vascular compression/rings, Tracheal stenosis/webs, Cystic lesions/masses, Cardiomegaly, Tumours</li>
                            <li><strong>Functional abnormalities:</strong> Gastroesophageal reflux, Recurrent aspiration, Cystic fibrosis, Immunodeficiency, Primary ciliary dyskinesia, Bronchopulmonary dysplasia, Retained foreign body (trachea or esophagus), Bronchiolitis obliterans, Pulmonary edema, Vocal cord dysfunction, Interstitial lung disease</li>
                        </ul>
                    </div>
                </section>
                <!-- END: differentials -->
                
                <!-- START: key-messages -->
                <section id="key-messages" class="content-section" aria-labelledby="section-heading-63">
                    <h2 id="section-heading-63" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Key Messages</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Asthma is a common disorder.</li>
                            <li>It can happen to anybody.</li>
                            <li>It is not caused by supernatural forces.</li>
                            <li>Asthma is not contagious.</li>
                            <li>It produces recurrent attacks of cough with or without wheeze.</li>
                            <li>Between attacks people with asthma lead normal lives as anyone else.</li>
                            <li>In most cases there is some history of allergy in the family.</li>
                        </ul>
                        <ul>
                            <li>Asthma can be effectively controlled, although it cannot be cured.</li>
                            <li>Effective asthma management programs include education, objective measures of lung function, environmental control, and pharmacologic therapy.</li>
                            <li>A stepwise approach to pharmacologic therapy is recommended. The aim is to accomplish the goals of therapy with the least possible medication.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: key-messages -->
                
                <!-- START: references -->
                <section id="references" class="content-section" aria-labelledby="section-heading-64">
                    <h2 id="section-heading-64" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">References</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Nelson's pediatrics</li>
                            <li>Harrison's principles of internal medicine-17<sup>th</sup> edition</li>
                            <li>Guidelines for asthma management in Kenya</li>
                            <li>GINA Guidelines for the diagnosis and management of asthma</li>
                        </ul>
                        <p style="text-align: center; font-weight: bold; margin-top: 2rem;">THANK YOU</p>
                    </div>
                </section>
                <!-- END: references -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="asthma-pharmacological-management.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 75%;"></div>
                        </div>
                       <span class="progress-text">Part 3 of 4</span>
                    </div>
                    <a href="status-astmaticus.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>